# Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis

> **NCT06674759** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 72 (estimated)

## Conditions studied

- Knee Osteoarthritis (Knee OA)

## Interventions

- **DRUG:** Tongren-Dahuoluo Bolus
- **DRUG:** Tongren-Dahuoluo Bolus Placebo

## Key facts

- **NCT ID:** NCT06674759
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06674759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06674759, "Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06674759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*